KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Revenue (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Revenue data on record, last reported at $2.2 billion in Q4 2025.

  • For Q4 2025, Revenue rose 10.9% year-over-year to $2.2 billion; the TTM value through Dec 2025 reached $8.2 billion, up 7.2%, while the annual FY2025 figure was $8.2 billion, 7.2% up from the prior year.
  • Revenue reached $2.2 billion in Q4 2025 per ZBH's latest filing, up from $2.0 billion in the prior quarter.
  • Across five years, Revenue topped out at $2.2 billion in Q4 2025 and bottomed at $1.6 billion in Q1 2021.
  • Average Revenue over 5 years is $1.9 billion, with a median of $1.8 billion recorded in 2022.
  • The widest YoY moves for Revenue: up 43.81% in 2021, down 14.77% in 2021.
  • A 5-year view of Revenue shows it stood at $1.8 billion in 2021, then grew by 2.7% to $1.8 billion in 2022, then rose by 6.3% to $1.9 billion in 2023, then rose by 4.28% to $2.0 billion in 2024, then increased by 10.9% to $2.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $2.2 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.1 billion in Q2 2025.